LILRB4, an immune checkpoint on myeloid cells

Area of Science:

• Immunology
• Cell Biology
• Molecular Biology

Background:

• Leukocyte immunoglobulin-like receptor B4 (LILRB4) is an inhibitory receptor within the LILR family.
• It is primarily expressed on human myeloid cells, both normal and malignant.
• LILRB4 plays a role in various physiological and pathological conditions.

Purpose of the Study:

• To elucidate the function of LILRB4 in myeloid cells.
• To explore the role of LILRB4 in disease pathogenesis.
• To evaluate LILRB4 as a potential therapeutic target.

Main Methods:

• Analysis of LILRB4 expression patterns.
• Investigation of LILRB4 signaling pathways upon ligand binding.
• Assessment of LILRB4's impact on T cell function.
• Correlation of LILRB4 expression with disease severity and patient survival.

Main Results:

• LILRB4 activation recruits adaptors to initiate signaling cascades.
• In normal myeloid cells, LILRB4 regulates cell activation and differentiation.
• In malignant myeloid cells, LILRB4 correlates with disease severity and suppresses T cells.

Conclusions:

• LILRB4 functions as an immune checkpoint on myeloid cells.
• LILRB4 is implicated in the pathogenesis of various diseases, including cancer.
• LILRB4 represents a promising therapeutic target for immune diseases and cancer immunotherapy.